ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

NCT00661076 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: adefovir dipivoxil
DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche